XJPX
7701
Market cap7.73bUSD
Oct 09, Last price
4,325.00JPY
1D
2.42%
1Q
4.47%
Jan 2017
132.28%
Name
Shimadzu Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shimadzu Corporation, established in Kyoto, Japan, in 1875, is a global enterprise recognized for its extensive range of cutting-edge instruments and machinery. The company's primary business activities are segmented across several key technological domains. Its analytical and measuring instrument division offers a comprehensive suite of products. This includes various chromatography and mass spectrometry systems (both gas and liquid), advanced tools for molecular and elemental analysis, surface analysis equipment, and essential instruments for life science laboratories. Additionally, they provide solutions for total organic carbon analysis, continuous process monitoring, thermal and particle size analysis, materials testing and inspection, non-destructive testing, and precision balances, all integrated with robust data management and software. In the medical systems sector, Shimadzu delivers state-of-the-art diagnostic imaging technologies. Their offerings span angiography and fluoroscopy systems, mobile C-arms, various radiography and X-ray systems (including mobile units), and fluorescence imaging products. Beyond medical, the company also manufactures high-precision optical and vacuum components, such as diffraction gratings, aspherical mirrors, laser mirrors, polka-dot beam splitters, and precision refractometers, alongside industrial vacuum equipment like turbo molecular pumps, helium leak detectors, sputtering and multi-deposition systems, and vacuum heat-treatment furnaces. Shimadzu's industrial machinery portfolio is diverse, featuring liquid delivery gear pumps, mechatronic systems like glass fiber winders and liquid crystal injection systems, and dynamic balancing machines. They also supply specialized hydraulic equipment, including hydraulic gear pumps, power packages, and multi-control valves. Lastly, the company contributes to the aerospace industry by producing critical aircraft equipment, such as electro-mechanical actuators, sophisticated flight control systems, and landing gear systems.
Key people
Toshiyuki Kono
Executive Officer, Director of Research Institute for Fundamental Technology · since 2025
Haruhiko Miyagawa
Executive Officer, Director of Technology, Deputy Director of Business in Analysis and Measurement Unit · since 2025
Yasuo Miyauchi
Executive Officer, Deputy Chief Director of Main Sales Unit, Manager of Global Co-creation Sales Strategy Office · since 2025
Naomi Okazaki
Executive Officer, Deputy Director of Analysis and Measurement Business · since 2022
Akira Okubo
Executive Officer, Senior Director of DX.IT Strategy · since 2025
Manabu Sakamoto
Executive Officer, President of Subsidiaries · since 2024
Kazuya Suzuki
Executive Officer, Director of Global Marketing, Deputy Director in Medical Equipment Unit · since 2023
Wataru Tajima
Executive Officer, Deputy Chief Director of Sales, Manager of Overseas Sales Unit · since 2024
Chairman of the Board, Chairman of the Board of Directors, Executive Officer, Representative Director · since 2022
Susumu Yamamoto
Executive Officer, Director of Aviation Equipment Business · since 2021
Akira Watanabe
Senior Managing Executive Officer, Chief Financial Officer, Director · since 2022
Mie Kitano
Independent Director · since 2024
Non-Executive Independent Director · since 2022
Non-Executive Independent Director · since 2020
Yoshiyuki Nakanishi
Non-Executive Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||